-
公开(公告)号:WO2022093852A1
公开(公告)日:2022-05-05
申请号:PCT/US2021/056696
申请日:2021-10-26
申请人: IMARA INC. , VANDERBILT UNIVERSITY
IPC分类号: A61K31/4985 , A61K31/505 , A61P9/00 , C07D487/02 , C07D487/04
摘要: The present disclosure relates to PDE9 inhibitors, compositions comprising the PDE9 inhibitors, and methods of using the PDE9 inhibitors and compositions for treatment of cardiac failure.
-
公开(公告)号:WO2022036111A1
公开(公告)日:2022-02-17
申请号:PCT/US2021/045765
申请日:2021-08-12
申请人: IMARA INC.
发明人: BALLAL, Rahul Dilip
IPC分类号: A61P13/08 , A61P7/00 , C07D487/04
摘要: The present disclosure relates to methods for decreasing or increasing one or more biomarkers by administering PDE9 pharmaceutical compositions comprising 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (Compound 1), or a pharmaceutically acceptable salt, solvate, or polymorph thereof, in a patient suffering from sickle cell disease (SCD) and/or sickle cell anemia (SCA).
-
公开(公告)号:WO2023014748A1
公开(公告)日:2023-02-09
申请号:PCT/US2022/039217
申请日:2022-08-02
申请人: IMARA INC.
发明人: BALLAL, Rahul Dilip
IPC分类号: A61K31/201 , A61K31/231 , A61K31/202 , A61K48/00
摘要: The present disclosure relates to methods of using nitrated fatty acids such as 10-nitro-9(E)-octadec-9-enoic acid (Compound 1), or a pharmaceutically acceptable salt or solvate thereof, in the treatment in sickle cell disease.
-
-